Investment Research & Advisory Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.2K Buy
410
+2
+0.5% +$264 0.02% 130
2026
Q1
$67.9K Buy
408
+2
+0.5% +$280 0.02% 110
2025
Q4
$53.2K Buy
406
+2
+0.5% +$243 0.02% 116
2025
Q3
$47.9K Buy
404
+2
+0.5% +$227 0.02% 116
2025
Q2
$44.6K Buy
402
+2
+0.5% +$213 0.02% 112
2025
Q1
$44.8K Buy
400
+100
+33% +$10.3K 0.02% 115
2024
Q4
$27.7K Hold
300
0.01% 125
2024
Q3
$25.2K Hold
300
0.01% 124
2024
Q2
$20.6K Hold
300
0.01% 125
2024
Q1
$22K Hold
300
0.01% 125
2023
Q4
$24.3K Hold
300
0.01% 116
2023
Q3
$22.5K Hold
300
0.01% 119
2023
Q2
$23.1K Hold
300
0.01% 126
2023
Q1
$24.9K Hold
300
0.02% 113
2022
Q4
$25.8K Hold
300
0.02% 110
2022
Q3
$19K Hold
300
0.01% 113
2022
Q2
$19K Hold
300
0.01% 117
2022
Q1
$18K Hold
300
0.01% 133
2021
Q4
$22K Hold
300
0.01% 129
2021
Q3
$21K Hold
300
0.01% 118
2021
Q2
$21K Hold
300
0.01% 126
2021
Q1
$19K Hold
300
0.01% 119
2020
Q4
$17K Hold
300
0.01% 121
2020
Q3
$19K Sell
300
-26
-8% -$1.8K 0.02% 117
2020
Q2
$25K Hold
326
0.02% 109
2020
Q1
$24K Hold
326
0.02% 105
2019
Q4
$21K Buy
+326
New +$21.2K 0.02% 132

Other funds holding GILD

Investment Research & Advisory Group's GILD Position: Q2 2026 in Review

Investment Research & Advisory Group increased its Gilead Sciences (GILD) stake by 0.49% in Q2 2026, buying an estimated $264 and bringing the position to 410 shares worth $55.2K. The position accounts for 0.02% of the portfolio, ranked #130.

Investment Research & Advisory Group first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $67.9K in Q1 2026. 911 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Investment Research & Advisory Group held 410 shares of Gilead Sciences worth $55.2K as of Q2 2026.
  • Investment Research & Advisory Group bought 2 Gilead Sciences shares in Q2 2026, an estimated $264.
  • Gilead Sciences made up 0.02% of Investment Research & Advisory Group's portfolio in Q2 2026, its #130 holding.
  • Investment Research & Advisory Group first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Investment Research & Advisory Group's Gilead Sciences position peaked at $67.9K in Q1 2026.
  • 911 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.